Viewing Study NCT00329966


Ignite Creation Date: 2025-12-24 @ 4:38 PM
Ignite Modification Date: 2026-01-22 @ 4:20 AM
Study NCT ID: NCT00329966
Status: COMPLETED
Last Update Posted: 2006-09-14
First Post: 2006-05-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: V71P4S
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View